| Dual targeting of WEE1 and PLK1 by AZD1775 elicits single agent cellular anticancer activity G Wright, V Golubeva, LL Remsing Rix, N Berndt, Y Luo, GA Ward, ... ACS chemical biology 12 (7), 1883-1892, 2017 | 68 | 2017 |
| Assessment of ASC specks as a putative biomarker of pyroptosis in myelodysplastic syndromes: an observational cohort study AA Basiorka, KL McGraw, F Abbas-Aghababazadeh, AF McLemore, ... The Lancet Haematology 5 (9), e393-e402, 2018 | 52 | 2018 |
| Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromes GA Ward, KL McGraw, F Abbas-Aghababazadeh, BS Meyer, ... Blood advances 5 (8), 2216-2228, 2021 | 31 | 2021 |
| Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma P Cheng, X Chen, R Dalton, A Calescibetta, T So, D Gilvary, G Ward, ... Molecular Therapy 30 (6), 2315-2326, 2022 | 26 | 2022 |
| Somatic gene mutations expose cytoplasmic DNA to co-opt the cGAS/STING/NLRP3 axis in myelodysplastic syndromes AF McLemore, HA Hou, BS Meyer, NB Lam, GA Ward, AL Aldrich, ... JCI insight 7 (15), 2022 | 18 | 2022 |
| Association of S100A8/A9 with lipid-rich necrotic core and treatment with biologic therapy in patients with psoriasis: Results from an observational cohort study AR Berg, CG Hong, M Svirydava, H Li, PM Parel, E Florida, R O’Hagan, ... Journal of Investigative Dermatology 142 (11), 2909-2919, 2022 | 10 | 2022 |
| Oxidized mitochondrial DNA engages TLR9 to activate the NLRP3 inflammasome in myelodysplastic syndromes GA Ward, RP Dalton III, BS Meyer, AF McLemore, AL Aldrich, NB Lam, ... International Journal of Molecular Sciences 24 (4), 3896, 2023 | 9 | 2023 |
| Constitutively activated DAP12 induces functional anti-tumor activation and maturation of human monocyte-derived DC R Dalton, A Calescibetta, JM Zhou, M Maurin, G Ward, TL Trinh, N Tu, ... International Journal of Molecular Sciences 22 (3), 1241, 2021 | 6 | 2021 |
| CX3CR1 deficiency-induced TIL tumor restriction as a novel addition for CAR-T design in solid malignancies TL Trinh, WA Adams, A Calescibetta, N Tu, R Dalton, T So, M Wei, G Ward, ... Iscience 26 (4), 2023 | 5 | 2023 |
| Oxidized mitochondrial DNA engages TLR9 to activate the NLRP3 inflammasome in myelodysplastic syndromes GA Ward, K McGraw, AF McLemore, NB Lam, HA Hou, BS Meyer, AF List Blood 134, 774, 2019 | 5 | 2019 |
| Genomic-DNA exposed by somatic gene mutations engages the cGAS/STING axis to license the NLRP3 inflammasome in myelodysplastic syndromes AF McLemore, KL McGraw, HA Hou, GA Ward, AH Onimus, ND Vincelette, ... Blood 132 (Supplement 1), 3075-3075, 2018 | 2 | 2018 |
| Circulating oxidized mtDNA is associated broadly with cardiovascular disease in a longitudinal cohort study of psoriasis SS Lateef, GA Ward, H Li, C Pantoja, E Florida, CG Hong, J Rodante, ... JID Innovations 4 (1), 100243, 2024 | 1 | 2024 |
| Oxidized mitochondrial DNA is a catalyst and biomarker of pyroptotic cell death in myelodysplastic syndromes GA Ward, KL McGraw, AF McLemore, F Abbas-Aghababazadeh, HA Hou, ... Blood 132, 3076, 2018 | 1 | 2018 |
| 1516 Advancing immunotherapy through patient-identified regulators of T cell stemness C Zebley, TG Kang, T Mi, S Alli, G Ward, AB Vasandan, S Carson, X Lan, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 2), 2023 | | 2023 |
| Effects of targeted epigenetic modifications on T–cell reprogramming AR Norman, GA Ward, CC Zebley, BA Youngblood The Journal of Immunology 210 (1_Supplement), 148.09-148.09, 2023 | | 2023 |
| TLR9-Selective Therapeutic Targeting of MDS Clones with a CpG Payload-Delivery Strategy GA Ward, S Christiansen, G Wright, S Wei, AF List, K Wright, EA Eksioglu Blood 140 (Supplement 1), 12306-12307, 2022 | | 2022 |
| Defining the Role of Oxidized Mitochondrial DNA in Myelodysplastic Syndromes GA Ward University of South Florida, 2022 | | 2022 |
